Hide Kaneda
Nihon University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hide Kaneda.
Pancreas | 2012
Kiminobu Sugito; Takeshi Furuya; Hide Kaneda; Takayuki Masuko; Kensuke Ohashi; Mikiya Inoue; Taro Ikeda; Tsugumichi Koshinaga; Ryouichi Tomita; Toshiya Maebayashi
Objectives The objectives of the present study were to determine nutritional status, pancreatic function, and morphological changes of the pancreatic remnant after pancreatic tumor resection in children. Methods The nutritional status was evaluated by the patterns of growth. Pancreatic function was evaluated by using a questionnaire, the Bristol stool form chart, the serum levels of fasting blood glucose, and hemoglobin A1c (HbA1c). Morphological changes of the pancreatic remnant were evaluated by computed tomography, magnetic resonance image, or magnetic resonance cholangiopancreatography. Results The present study consisted of 6 patients with pancreatic tumor (5 solid pseudopapillary tumors of the pancreas and 1 pancreatoblastoma) who underwent the following operations: tumor enucleation (3), distal pancreatectomy with splenectomy (1), and pylorus-preserving pancreatoduodenectomy (PPPD [2]). The serum levels of HbA1c have been gradually elevated in 2 patients with PPPD. A significant decrease in pancreatic parenchymal thickness and dilatation of the main pancreatic duct were observed in 2 patients with PPPD. Conclusion Endocrine pancreatic insufficiency after PPPD may be explainable by obstructive pancreatitis after operation. Taking together the results of pancreatic endocrine function and morphological changes of pancreatic remnant after PPPD, tumor enucleation should be considered as surgical approach in children with pancreas head tumor whenever possible.
Journal of Pediatric Surgery | 2013
Kiminobu Sugito; Hiroyuki Kawashima; Shinsuke Yoshizawa; Shota Uekusa; Reina Hoshi; Takeshi Furuya; Hide Kaneda; Toshifumi Hosoda; Noriyoshi Konuma; Takayuki Masuko; Kensuke Ohashi; Taro Ikeda; Tsugumichi Koshinaga; Ryouichi Tomita; Yui Shinojima; Kyoko Fujiwara; Takao Watanabe; William A. Held; Hiroki Nagase
BACKGROUND The comprehensive methylation analysis of tumor-specific differently methylated regions in malignant melanomas and brain tumors has led to the identification of non-promoter hypermethylation of zygote arrest 1 (ZAR1). To search the non-promoter ZAR1 hypermethylation in neuroblastomas, we analyzed the levels of the methylation and transcript expression of ZAR1. METHODS The MassARRAY® EpiTYPER (Sequenom Inc., San Diego, CA, USA) system was optimized to determine the quantitative methylation levels of ZAR1 for 12 neuroblastoma cell lines, 23 neuroblastoma samples and four adrenal samples. ZAR1 expression levels were evaluated through a quantitative, real-time reverse transcription-polymerase chain reaction. The quantitative methylation levels of ZAR1 were subjected to correlation studies with the established markers of progressive disease and outcome. RESULTS Strikingly, the hypermethylation of ZAR1 regions and ZAR1 expression levels was observed in the neuroblastoma cell lines and neuroblastoma samples, compared to the adrenal samples. Somatic changes in ZAR1 methylation and ZAR1 expression were found in all three neuroblastoma patients. In the ZAR1 regions, poor-outcome tumors that were MYCN-amplified and/or Stage 3 or 4 and/or the age at diagnosis was≥18months, and/or showed an unfavorable histology were frequently hypermethylated. CONCLUSION Our results indicate that the hypermethylation of ZAR1 regions is extremely frequent in neuroblastomas and correlates with established markers of progressive disease and outcome.
Pediatric Blood & Cancer | 2013
Kiminobu Sugito; Hiroyuki Kawashima; Shota Uekusa; Shinsuke Yoshizawa; Reina Hoshi; Takeshi Furuya; Hide Kaneda; Toshifumi Hosoda; Takayuki Masuko; Kensuke Ohashi; Taro Ikeda; Tsugumichi Koshinaga; Kyoko Fujiwara; Jun Igarashi; Srimoyee Ghosh; William A. Held; Hiroki Nagase
The identification of tissue‐specific differentially methylated regions (tDMRs) is key to our understanding of mammalian development. Research has indicated that tDMRs are aberrantly methylated in cancer and may affect the oncogenic process.
Journal of Pediatric Surgery | 2015
Takashi Hosokawa; Noriyoshi Konuma; Taro Ikeda; Makoto Hashimoto; Hide Kaneda; Kensuke Ohashi; Taro Matsumoto; Tsugumichi Koshinaga
BACKGROUND/PURPOSE Mainstream models for anal sphincter injury use large animals. We developed a simple and stable anal sphincter injury model in a small animal (i.e., rats) to obtain manometry measurements by using a miniaturized probe and applying cardiotoxin. METHODS The histological structure of the anal canal was evaluated by using manometry in normal rats (n=40). We damaged the internal and external anal sphincters by locally administering snake poison (cardiotoxin; 20 uM, 100μL 8 points). We evaluated the anal canal function through manometry measurements (n=5) and examined the histology using hematoxylin-eosin staining (at each time point, n=3; total n=15). RESULTS The manometry parameters and structure of the anal canal of normal rats were similar to those of humans, because rats have resting pressure, rectoanal reflex in the manometry, and an external and internal anal sphincter. After inducing injury, the following findings were observed: rhythmic wave loss and a remarkable reduction in the anal sphincter resting pressure; and local bleeding and advanced infiltration of the inflammatory cells (day 1) and the loss of muscle fibers (day 3). CONCLUSION This new rat model will contribute to increasing the knowledge on the anal canal.
Journal of Pediatric Surgery | 2011
Kiminobu Sugito; Takeshi Furuya; Hide Kaneda; Takayuki Masuko; Kensuke Ohashi; Mikiya Inoue; Taro Ikeda; Tsugumichi Koshinaga; Hiroshi Yagasaki; Hideo Mugishima; Toshiya Maebayashi
The local control of neuroblastoma is a very important treatment consideration. We describe a patient who received high-dose rate 60Co remote after loading system treatment for local control of recurrent neuroblastoma and discuss the efficacy of high-dose rate 60Co remote after loading system treatment.
Hernia | 2014
M. Hoshino; Kiminobu Sugito; Hiroyuki Kawashima; S. Goto; Hide Kaneda; Takeshi Furuya; Toshifumi Hosoda; Takayuki Masuko; Kensuke Ohashi; Mitsuru Inoue; Tarou Ikeda; Ryouichi Tomita; Tsugumichi Koshinaga
Indian Journal of Surgery | 2015
Takeshi Furuya; Mikiya Inoue; Kiminobu Sugito; Shumpei Goto; Hiroyuki Kawashima; Hide Kaneda; Takayuki Masuko; Kensuke Ohashi; Taro Ikeda; Tsugumichi Koshinaga
Hernia | 2015
Hide Kaneda; Takeshi Furuya; Kiminobu Sugito; S. Goto; Hiroyuki Kawashima; Mitsuru Inoue; Toshifumi Hosoda; Takayuki Masuko; Kensuke Ohashi; Tarou Ikeda; Tsugumichi Koshinaga; Mayumi Hoshino; Hiroshi Goto
BMC Pediatrics | 2018
Tsugumichi Koshinaga; Kensuke Ohashi; Kakou Ono; Hide Kaneda; Takeshi Furuya
Journal of Pediatric Surgery | 2017
Kensuke Ohashi; Tsugumichi Koshinaga; Shuichiro Uehara; Takeshi Furuya; Hide Kaneda; Hiroyuki Kawashima; Taro Ikeda